SOLV

Vorhandelsmarkt: 76.19 -9.08 -10.65%

Solventum Corp (SOLV)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Solventum Corp Stock (SOLV) Company Profile

Solventum Corp

Healthcare (1137)

651-733-1110

C/O 3M COMPANY, ST. PAUL

Nächster Verdiensttermin

Neueste SEC-Einreichungen

SOLV's Discussions on Twitter

Vergleichen Sie SOLV mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
SOLV Solventum Corp	85.27	14.88B	8.31B	379.00M	385.00M	2.16
ISRG Intuitive Surgical Inc	574.23	205.21B	9.61B	2.77B	2.27B	7.555
BDX Becton Dickinson Co	193.90	56.03B	21.84B	1.68B	2.67B	5.8322
ALC Alcon Inc	79.17	39.13B	10.19B	1.05B	1.38B	2.1044
RMD Resmed Inc	255.04	37.34B	5.26B	1.44B	1.76B	9.7713
WST West Pharmaceutical Services Inc	277.14	20.20B	2.96B	487.70M	344.00M	6.6758

Solventum Corp Stock (SOLV) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-10-01	Eingeleitet	UBS	Neutral
2025-09-11	Eingeleitet	Jefferies	Hold
2025-07-15	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2025-07-01	Hochstufung	Argus	Hold → Buy
2025-06-06	Eingeleitet	KeyBanc Capital Markets	Sector Weight
2025-05-19	Hochstufung	Piper Sandler	Neutral → Overweight
2024-12-04	Eingeleitet	Mizuho	Neutral
2024-10-08	Eingeleitet	Stifel	Buy
2024-10-07	Eingeleitet	Piper Sandler	Neutral
2024-09-26	Eingeleitet	Wolfe Research	Peer Perform
2024-09-05	Eingeleitet	BTIG Research	Neutral
2024-06-24	Eingeleitet	Argus	Hold
2024-05-30	Eingeleitet	Goldman	Sell
2024-05-10	Eingeleitet	BofA Securities	Neutral
2024-04-10	Eingeleitet	Morgan Stanley	Equal-Weight
2024-04-08	Eingeleitet	Wells Fargo	Equal Weight
2024-04-02	Eingeleitet	Edward Jones	Hold

Alle ansehen

Solventum Corp Aktie (SOLV) Neueste Nachrichten

Finanzdaten der Solventum Corp-Aktie (SOLV)

Solventum Corp (SOLV)

Solventum Corp Stock (SOLV) Company Profile

Vergleichen Sie SOLV mit anderen Aktien

Solventum Corp Stock (SOLV) Upgrades & Downgrades

Solventum Corp Aktie (SOLV) Neueste Nachrichten

The Beat: ShopFloor Coffee eyes Walmart; Apasa Foods strategy, Solventum deal - The Business Journals

Is Solventum’s (SOLV) Billion-Dollar Buyback a Signal of Strength or Strategic Caution? - simplywall.st

Solventum's second-quarter profit falls 70% on higher expenses - AOL.com

Solventum Corp (1SOLV.MI) Stock Major Holders - Yahoo! Finance Canada

Solventum to Participate in the 2025 Piper Sandler Healthcare Conference - Eastern Progress

9-Day Rally Sends Solventum Stock Up 16% - Trefis

Solventum Corp. stock rises Tuesday, outperforms market - MarketWatch

Solventum Corp stock hits 52-week high at 85.92 USD By Investing.com - Investing.com South Africa

Model ML raises again, gene-editing gains backers and Solventum's wound care buy - Axios

Solventum to buy private wound care firm Acera for up to $850M - MSN

Solventum Stock Surges 13%, With A 8-Day Winning Spree - Trefis

Solventum to acquire Acera Surgical in $725 million deal - Indian Pharma Post

Solventum (SOLV): Assessing Valuation After $1 Billion Share Buyback Announcement - Yahoo Finance

Solventum Seeks to Chart Its Own Path, Improve Operations, and Raise Profitability - Morningstar

Solventum bolsters wound care portfolio with $850m Acera Surgical acquisition - Yahoo Finance

Solventum to buy Acera Surgical for up to $850M, repurchase $1B in stock - Fierce Biotech

Solventum to Acquire Acera Surgical in $725 Mn Deal to Boost Regenerative Wound-Care Portfolio - Digital Health News

Stocks Flashing Renewed Technical Strength: Solventum - Investor's Business Daily

Solventum: Setting Up For Growth And A Re-Rating (NYSE:SOLV) - Seeking Alpha

Solventum sets $1 billion share repurchase program - MSN

Quick ratio of Solventum Corporation – HAM:KB7 - TradingView

Solventum To Buy Acera Surgical In $850 Million Deal To Expand Advanced Wound Care Portfolio - Pulse 2.0

Solventum stock rating reiterated by UBS, Acera deal fills wound care gap - Investing.com South Africa

Teleflex, Solventum, Haemonetics, Centene, and Molina Healthcare Shares Skyrocket, What You Need To Know - Finviz

Solventum Corporation Reports Strong Q3 2025 Results - MSN

Solventum Stock Gets Relative Strength Rating Lift - Investor's Business Daily

A Look at Solventum’s Valuation Following $1 Billion Share Buyback Authorization - simplywall.st

Acera Surgical, born from WashU research, to be acquired for up to $850M - The Business Journals

Agree To Buy Solventum At $70, Earn 6.6% Annualized Using Options - Nasdaq

Solventum inks $725M Acera takeover - MedTech Dive

Solventum Trying To Close In On Key Technical Measure - MSN

Solventum stock rating reiterated by UBS, Acera deal fills wound care gap By Investing.com - Investing.com Nigeria

Solventum agrees to buy regenerative wound care maker Acera Surgical for $725M+ - The Business Journals

How institutional buying supports Solventum Corporation stock2025 Earnings Impact & Safe Capital Allocation Plans - newser.com

Solventum Corporation: Hold Rating Amid Strategic Moves and Growth Challenges - TipRanks

Solventum to acquire Acera Surgical - Medical Buyer

How Solventum Corporation stock behaves in tightening cyclesBear Alert & AI Powered Buy and Sell Recommendations - newser.com

Strategic Acquisition and Capital Management Propel Solventum Corporation’s Growth Potential - TipRanks

Solventum announces $1 billion share repurchase program By Investing.com - Investing.com Nigeria

Solventum to acquire Acera Surgical for $725 million By Investing.com - Investing.com Nigeria

Solventum Corp. stock rises Thursday, outperforms market - MarketWatch

Solventum stock rises on $1 billion share buyback, Acera acquisition By Investing.com - Investing.com Nigeria

Solventum stock rises on $1 billion share buyback, Acera acquisition - Investing.com

Solventum to Acquire Acera Surgical for $850M - Medical Device and Diagnostic industry

Solventum to acquire soft tissue repair company Acera Surgical, repurchase $1B in shares - MassDevice

Solventum Corporation entered into a definitive agreement to acquire Acera Surgical, Inc. for $850 million. - MarketScreener

Solventum agrees to acquire Acera for up to $850M - BioWorld MedTech

Finanzdaten der Solventum Corp-Aktie (SOLV)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie SOLV